Study of ulixacaltamide for essential tremor
Part of Brain & nervous system clinical trials.
This study tests whether the drug ulixacaltamide can safely reduce tremors in people with essential tremor, a condition that causes shaking of the hands and arms. It is a phase 3 trial, meaning it is in the final stages of testing before possible approval.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of essential tremor, which causes shaking during movement or when holding a posture, like holding a cup.
- You are not taking more than one medication for essential tremor, and the dose has been stable for at least one month.
- You are not using primidone (a tremor medication) at least 2 weeks before the study starts.
- You are willing to avoid alcohol for 24 hours before and during study assessments.
- You have not had surgery or focused ultrasound for tremor, and no botulinum toxin (Botox) injections for tremor in the last 6 months.
- You are willing to use effective contraception if you could become pregnant or father a child.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new study drug (BP1.4979) to see if it can reduce shaking in people with essential tremor. It's for people who have had arm tremors for at least 3 years and have not had surgery for tremor.
This study tests whether a second focused ultrasound treatment on the other side of the brain can safely and effectively reduce tremor in people with essential tremor who already had one treatment. It's for those whose tremor is not well controlled by medication or previous treatments.
This study tests whether ultrasound waves applied to a part of the brain (the cerebellum) can safely affect brain activity. It involves healthy volunteers and people with essential tremor, a condition causing shaky hands, to see if this approach might help.
This study is testing a new way to treat essential tremor using focused ultrasound waves guided by MRI to target the part of the brain causing the tremor. The goal is to see if it can reduce tremor without invasive surgery.
This trial tests a second focused ultrasound treatment for people with essential tremor who have already had one side treated. It checks if treating the other side helps control tremors better.
This early-stage study tests whether focused ultrasound waves can safely reduce hand tremors in people with essential tremor. The ultrasound is applied from outside the skin without surgery, and researchers want to see if it helps calm unwanted shaking.
Hear when a new Essential Tremor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.